生命科学资讯

Deep-learning analysis of 3D microarchitectural remodeling in hypertrophic cardiomyopathy | Science

FDA to meet Novo Nordisk on troubled site; AbbVie buys drug-device factory

Ocugen touts Phase 2 data for eye disease gene therapy

Waters Corporation Earnings Preview: What to Expect - Barchart.com

Waters Corporation Earnings Preview: What to Expect - FinancialContent

It’s crunch time for US biopharma M&A. Can drugmakers strike deals despite persisting anxieties?

Neurocrine Biosciences describes new GLP-1R/GIPR/GCGR agonists

Biolexis Therapeutics presents new AMPK activators

Chinese scientists patent new CYP11B2 inhibitors

Chengdu Zeling Biomedical Technology identifies new RIPK1 inhibitors

Gan & Lee Pharmaceuticals discloses new ER-α degradation inducers

Novo Nordisk Foundation invests $860M in Danish institute nurturing homegrown biotechs

All the meetings, none of the megadeals: Is JPM's purpose evolving?

Italy's Alfasigma pens €125M deal for injectable form of German biotech's HSV treatment

J&J reports positive Phase 3 data for Tecvayli in earlier blood cancer setting

Nordea Investment Management AB Has $82.14 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat

Sumitomo Mitsui Trust Group Inc. Sells 636,744 Shares of 10x Genomics $TXG - MarketBeat

Why 10x Genomics (TXG) shares are falling today - MSN

Eastern Bank Sells 53,575 Shares of Agilent Technologies, Inc. $A - MarketBeat

Agilent Technologies (A) Valuation Check After Evercore ISI Upgrade And Growing Analyst Optimism - Sahm